Chronic Kidney Disease Trial, Recruiting NCT06278207 Sponsor: Bayer Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06278207
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been continuously receiving medical care from the same healthcare providers (with both medical and pharmacy records) for at least 12 months before the start date.
  • People who have not been prescribed the medication finerenone at any point in the 12 months before the start date.
  • People who are 18 years of age or older as of the start date.
  • People who have a recorded diagnosis of Type 2 diabetes at any point up to and including the start date.
  • People who have evidence of moderate chronic kidney disease (stages 2–4), which the trial defines as having at least one of the following on record: a diagnosis code for chronic kidney disease stage 2, 3, 4, or unspecified; two urine protein test results showing kidney leakage (≥30 mg/g) taken at least 90 days apart but no more than 540 days apart; or two kidney function test results showing reduced but not severely low kidney function, also taken at least 90 days apart but no more than 540 days apart (confirm with trial site).

Who may not be able to join:

  • People whose records show two kidney function test results indicating very low kidney function (below a certain threshold), taken at least 90 days apart but no more than 540 days apart.
  • People who have been dependent on dialysis, meaning they have had at least three dialysis sessions over a period of at least 90 days during the review period.
  • People who have a recorded diagnosis of kidney failure or the most severe stage of chronic kidney disease (stage 5).
  • People who have had a kidney transplant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (+)1-888-84 22937

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
15 May 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇩🇪 Germany 🇯🇵 Japan 🇹🇼 Taiwan 🇺🇸 United States

Primary endpoints

Participants' characteristics at baseline in a cohort of participants with CKD and T2D who initiate finerenone.; Participants' comorbidities at baseline in a cohort of participants with CKD and T2D who initiate finerenone.; Participants' comedications at baseline in a cohort of participants with CKD and T2D who initiate finerenone.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov